BTC Health Ltd - Asset Resilience Ratio
BTC Health Ltd (BTC) has an Asset Resilience Ratio of 14.52% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check BTC Health Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2004–2025)
This chart shows how BTC Health Ltd's Asset Resilience Ratio has changed over time. See BTC Health Ltd net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down BTC Health Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BTC Health Ltd (BTC) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$1.64 Million | 14.52% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$1.64 Million | 14.52% |
Asset Resilience Insights
- Moderate Liquidity: BTC Health Ltd has 14.52% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
BTC Health Ltd Industry Peers by Asset Resilience Ratio
Compare BTC Health Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Revolution Medicines Inc
NASDAQ:RVMD |
Biotechnology | 65.10% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 0.05% |
|
Hugel Inc
KQ:145020 |
Biotechnology | 29.57% |
|
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX |
Biotechnology | 39.07% |
|
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076 |
Biotechnology | 2.30% |
|
Absci Corp
NASDAQ:ABSI |
Biotechnology | 59.86% |
|
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880 |
Biotechnology | 5.52% |
|
Lifecome Biochemistry Co Ltd
SHE:002868 |
Biotechnology | 4.69% |
Annual Asset Resilience Ratio for BTC Health Ltd (2004–2025)
The table below shows the annual Asset Resilience Ratio data for BTC Health Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 6.63% | AU$620.11K ≈ $438.77K |
AU$9.36 Million ≈ $6.62 Million |
-32.65pp |
| 2024-06-30 | 39.27% | AU$2.02 Million ≈ $1.43 Million |
AU$5.15 Million ≈ $3.64 Million |
-19.77pp |
| 2023-06-30 | 59.04% | AU$1.74 Million ≈ $1.23 Million |
AU$2.94 Million ≈ $2.08 Million |
+42.37pp |
| 2022-06-30 | 16.67% | AU$2.17 Million ≈ $1.54 Million |
AU$13.02 Million ≈ $9.21 Million |
-1.57pp |
| 2021-06-30 | 18.25% | AU$2.37 Million ≈ $1.68 Million |
AU$12.98 Million ≈ $9.19 Million |
-10.25pp |
| 2020-06-30 | 28.50% | AU$3.27 Million ≈ $2.31 Million |
AU$11.46 Million ≈ $8.11 Million |
-8.35pp |
| 2019-06-30 | 36.84% | AU$4.32 Million ≈ $3.06 Million |
AU$11.72 Million ≈ $8.29 Million |
-43.52pp |
| 2018-06-30 | 80.36% | AU$2.66 Million ≈ $1.89 Million |
AU$3.32 Million ≈ $2.35 Million |
+13.76pp |
| 2017-06-30 | 66.60% | AU$3.11 Million ≈ $2.20 Million |
AU$4.67 Million ≈ $3.30 Million |
+0.18pp |
| 2015-06-30 | 66.41% | AU$700.00K ≈ $495.29K |
AU$1.05 Million ≈ $745.76K |
-11.41pp |
| 2014-06-30 | 77.83% | AU$1.00 Million ≈ $707.56K |
AU$1.28 Million ≈ $909.13K |
-8.58pp |
| 2013-06-30 | 86.41% | AU$2.74 Million ≈ $1.94 Million |
AU$3.17 Million ≈ $2.24 Million |
+4.22pp |
| 2012-06-30 | 82.19% | AU$4.05 Million ≈ $2.87 Million |
AU$4.93 Million ≈ $3.49 Million |
+16.10pp |
| 2011-06-30 | 66.10% | AU$7.76 Million ≈ $5.49 Million |
AU$11.75 Million ≈ $8.31 Million |
+7.80pp |
| 2010-06-30 | 58.30% | AU$9.41 Million ≈ $6.66 Million |
AU$16.14 Million ≈ $11.42 Million |
+54.67pp |
| 2009-06-30 | 3.63% | AU$851.00K ≈ $602.14K |
AU$23.45 Million ≈ $16.59 Million |
-5.40pp |
| 2006-06-30 | 9.03% | AU$4.33 Million ≈ $3.06 Million |
AU$47.93 Million ≈ $33.91 Million |
-24.68pp |
| 2004-06-30 | 33.71% | AU$16.28 Million ≈ $11.52 Million |
AU$48.30 Million ≈ $34.18 Million |
-- |
About BTC Health Ltd
BTC Health Limited is a Pooled Development Fund managed by LHC Capital Partners Pty Ltd specializing in seed/startup, early venture, mid venture, late venture, emerging growth and growth capital investments. It makes investments in the healthcare, acute pain management, neuro-spinal, cardiovascular, pharmaceutical, medical technologies, biotechnology sector with a focus on post-genomics, stem cel… Read more